(1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus, (2) patients require mechanical ventilation, (3) People with metal or pacemaker, (4) active tuberculosis, (5) Massive pulmonary fibrosis, (6) Those with shock, (7) Those who have bleeding tendency or active bleeding in the lungs, (8) Patients with multiple organ failure who need ICU monitoring and treatment, (9) Patients with tumor and severe basic diseases, (10) pregnant or lactating women, (11) Patients with active tuberculosis, (12) Those with other contraindications to ultrashort wave, (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment, (14) Those without signed informed consent, (15) Researchers believe that other reasons are not suitable for clinical trials.

(1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus, (2) patients require mechanical ventilation, (3) People with metal or pacemaker, (4) active tuberculosis, (5) Massive pulmonary fibrosis, (6) Those with shock, (7) Those who have bleeding tendency or active bleeding in the lungs, (8) Patients with multiple organ failure who need ICU monitoring and treatment, (9) Patients with tumor and severe basic diseases, (10) pregnant or lactating women, (11) Patients with active tuberculosis, (12) Those with other contraindications to ultrashort wave, (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment, (14) Those without signed informed consent, (15) Researchers believe that other reasons are not suitable for clinical trials.

(1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus, (2) Respiratory failure occurs, requiring mechanical ventilation, (3) People with metal or pacemaker, (4) active tuberculosis, (5) Massive pulmonary fibrosis, (6) Those with shock, (7) Those who have bleeding tendency or active bleeding in the lungs, (8) Patients with multiple organ failure who need ICU monitoring and treatment, (9) Patients with tumor and severe basic diseases, (10) pregnant or lactating women, (11) Patients with active tuberculosis, (12) Those with other contraindications to ultrashort wave, (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment, (14) Those without signed informed consent, (15) Researchers believe that other reasons are not suitable for clinical trials.

(1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus, (2) Respiratory failure occurs, requiring mechanical ventilation, (3) People with metal or pacemaker, (4) active tuberculosis, (5) Massive pulmonary fibrosis, (6) Those with shock, (7) Those who have bleeding tendency or active bleeding in the lungs, (8) Patients with multiple organ failure who need ICU monitoring and treatment, (9) Patients with tumor and severe basic diseases, (10) pregnant or lactating women, (11) Patients with active tuberculosis, (12) Those with other contraindications to ultrashort wave, (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment, (14) Those without signed informed consent, (15) Researchers believe that other reasons are not suitable for clinical trials.